Literature DB >> 6383206

Penetration of ceftazidime into the cerebrospinal fluid of patients with and without evidence of meningeal inflammation.

I W Fong, K B Tomkins.   

Abstract

The concentrations of ceftazidime in the serum and cerebrospinal fluid of patients with and without meningitis were measured at various times after a 2- or 3-g dose. At similar concentrations in serum, ceftazidime concentrations in cerebrospinal fluid at a given time were substantially lower in patients without meningitis (mean, 0.8 micrograms/ml) than in those with meningitis (mean, 22.6 micrograms/ml).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6383206      PMCID: PMC179932          DOI: 10.1128/AAC.26.1.115

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

Review 1.  The penetration of antibiotics into cerebrospinal fluid and brain tissue.

Authors:  R W Barling; J B Selkon
Journal:  J Antimicrob Chemother       Date:  1978-05       Impact factor: 5.790

2.  Ceftazidime in clinical practice - a summary.

Authors:  S R Norrby
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

3.  Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis.

Authors:  J Modai; D Vittecoq; J M Decazes; M Wolff; A Meulemans
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

4.  Determination of ceftazidime in biological fluids by using high-pressure liquid chromatography.

Authors:  C M Myers; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

  4 in total
  12 in total

Review 1.  Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases.

Authors:  P S McKinnon; S L Davis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-10       Impact factor: 3.267

2.  [Rational parameters in the treatment of bacterial meningitis with modern cephalosporins].

Authors:  O Brückner; M Trautmann
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 3.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  Concentrations of ceftazidime, tobramycin and ampicillin in the cerebrospinal fluid of newborn infants.

Authors:  I Tessin; B Trollfors; K Thiringer; Z Thörn; P Larsson
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

Review 5.  Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.

Authors:  Nikolas J Onufrak; Alan Forrest; Daniel Gonzalez
Journal:  Clin Ther       Date:  2016-07-20       Impact factor: 3.393

Review 6.  Bacterial meningitis. Rational selection and use of antibacterial drugs.

Authors:  M Whitby; R Finch
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

7.  Distribution of [14C]aztreonam in rat tissue.

Authors:  S M Singhvi; C E Ita; J M Shaw; B H Migdalof
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

Review 8.  Bacterial meningitis: mechanisms of disease and therapy.

Authors:  R F Kornelisse; R de Groot; H J Neijens
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

9.  Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis.

Authors:  L Granero; M Santiago; J Cano; A Machado; J E Peris
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

10.  CSF pharmacokinetics of ceftazidime in neurosurgical patients with an external ventriculostomy.

Authors:  U Fuhr; S Harder; S Häfner; D Rosenthal; R Lorenz; A H Staib
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.